Fleming, G. F., Kurnit, K., Pelster, M., Munster, P. N., Wadlow, R. C., Koganemaru, S., Kitagawa, C., Nakajima, T. E., Maruki, Y., Perets, R., Badu-Nkansah, A., Blaney, M. E., Mehibel, M., Li, P., Seddiq, M., Shurshalina, A., Yacoub, O. N. A., Burns, M. C., Kitano, S. (2026). Phase 1 basket study of telisotuzumab adizutecan (Temab-A, ABBV-400), a c-Met protein–targeting antibody-drug conjugate: Results from patients with platinum-resistant ovarian/primary peritoneal/fallopian tube cancer (PROC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5514